Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell
Objectives The aim of the study was to prepare a sublingual formulation for piroxicam using a thermosensitive polymer and to evaluate its permeation through porcine sublingual mucosa. Methods Formulation technique utilized the transition property of poloxamer from solution state at room temperature...
Gespeichert in:
Veröffentlicht in: | Journal of pharmacy and pharmacology 2016-01, Vol.68 (1), p.26-35 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 35 |
---|---|
container_issue | 1 |
container_start_page | 26 |
container_title | Journal of pharmacy and pharmacology |
container_volume | 68 |
creator | Sivaraman, Arunprasad Banga, Ajay K. |
description | Objectives
The aim of the study was to prepare a sublingual formulation for piroxicam using a thermosensitive polymer and to evaluate its permeation through porcine sublingual mucosa.
Methods
Formulation technique utilized the transition property of poloxamer from solution state at room temperature to gel state at oromucosal temperature (37 °C). The permeation of the drug was evaluated using an inverted Franz diffusion cell technique that allowed the dosage form to be directly applied onto the substrate with required volume of saliva. The formulation was characterized for microscopy of the piroxicam crystals, sol–gel transition property and in‐vitro diffusion study.
Key findings
Poloxamer‐based formulation enhanced solubility and increased permeability of the piroxicam.
Conclusion
Poloxamer formulation with 0.1% w/w piroxicam delivered a cumulative amount of 11.99 ± 7.82 and 11.23 ± 1.79 μg/cm2, while non‐poloxamer formulation delivered 3.57 ± 2.20 and 4.60 ± 6.90 μg/cm2 with 0.1 and 0.5 ml artificial saliva, respectively, through porcine sublingual tissue in 6 h. A similar delivery profile was observed for 0.05% w/w piroxicam formulation as well. |
doi_str_mv | 10.1111/jphp.12493 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760917456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760917456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4653-782e45d00509574bfedb7d2d4c6afccb8b0e44f5b0979504e3031b44f8a146273</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EokNhwwMgS2wQUor_PVmilmmBEXQBFLGxnOSG8eDEwU7aDkueHIdpu2CBN5avz3ds6UPoKSVHNK9X22EzHFEmSn4PLRgRrNBULu-jBSGMFVxqfoAepbQlhGil1EN0wJSmQjC-QL9XIXaTt6MLPbZ9g-HS-ml_DC1OU-Vd_32yHjfg3SXE3TweXAzXrrYdnlK-xuMGYhcS9MmNGcJD8LsOIr5y4yZbsetzcoQGr6Ltf-HGtW0O5idq8P4xetBan-DJzX6IPq_efDo-K9YfT98ev14XtVCSF3rJQMiGEElKqUXVQlPphjWiVrat62pZERCilRUpdSmJAE44rfJkaalQTPND9GLvHWL4OUEaTefS_AHbQ5iSoVqRkmohVUaf_4NuwxT7_LtMyZIzQuksfLmn6hhSitCaIbrOxp2hxMzNmLkZ87eZDD-7UU5VB80deltFBugeuHIedv9RmXfnZ-e30mKfcWmE67uMjT-M0lxLc_Hh1JzIr-9X39ZfzAX_A9LJqoA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1759320117</pqid></control><display><type>article</type><title>Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sivaraman, Arunprasad ; Banga, Ajay K.</creator><creatorcontrib>Sivaraman, Arunprasad ; Banga, Ajay K.</creatorcontrib><description>Objectives
The aim of the study was to prepare a sublingual formulation for piroxicam using a thermosensitive polymer and to evaluate its permeation through porcine sublingual mucosa.
Methods
Formulation technique utilized the transition property of poloxamer from solution state at room temperature to gel state at oromucosal temperature (37 °C). The permeation of the drug was evaluated using an inverted Franz diffusion cell technique that allowed the dosage form to be directly applied onto the substrate with required volume of saliva. The formulation was characterized for microscopy of the piroxicam crystals, sol–gel transition property and in‐vitro diffusion study.
Key findings
Poloxamer‐based formulation enhanced solubility and increased permeability of the piroxicam.
Conclusion
Poloxamer formulation with 0.1% w/w piroxicam delivered a cumulative amount of 11.99 ± 7.82 and 11.23 ± 1.79 μg/cm2, while non‐poloxamer formulation delivered 3.57 ± 2.20 and 4.60 ± 6.90 μg/cm2 with 0.1 and 0.5 ml artificial saliva, respectively, through porcine sublingual tissue in 6 h. A similar delivery profile was observed for 0.05% w/w piroxicam formulation as well.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1111/jphp.12493</identifier><identifier>PMID: 26714423</identifier><identifier>CODEN: JPPMAB</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Administration, Sublingual ; Animals ; Chemistry, Pharmaceutical - methods ; Diffusion ; Drug Delivery Systems - methods ; Gels - administration & dosage ; Gels - chemistry ; inverted Franz diffusion cell ; Permeability ; piroxicam ; Piroxicam - administration & dosage ; Piroxicam - chemistry ; Polymers - administration & dosage ; Polymers - chemistry ; sol-gel transition ; Solutions - administration & dosage ; Solutions - chemistry ; sublingual delivery ; Swine ; Temperature ; thermosensitive polymer</subject><ispartof>Journal of pharmacy and pharmacology, 2016-01, Vol.68 (1), p.26-35</ispartof><rights>2015 Royal Pharmaceutical Society</rights><rights>2015 Royal Pharmaceutical Society.</rights><rights>Copyright © 2016 Royal Pharmaceutical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4653-782e45d00509574bfedb7d2d4c6afccb8b0e44f5b0979504e3031b44f8a146273</citedby><cites>FETCH-LOGICAL-c4653-782e45d00509574bfedb7d2d4c6afccb8b0e44f5b0979504e3031b44f8a146273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjphp.12493$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjphp.12493$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26714423$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sivaraman, Arunprasad</creatorcontrib><creatorcontrib>Banga, Ajay K.</creatorcontrib><title>Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>Objectives
The aim of the study was to prepare a sublingual formulation for piroxicam using a thermosensitive polymer and to evaluate its permeation through porcine sublingual mucosa.
Methods
Formulation technique utilized the transition property of poloxamer from solution state at room temperature to gel state at oromucosal temperature (37 °C). The permeation of the drug was evaluated using an inverted Franz diffusion cell technique that allowed the dosage form to be directly applied onto the substrate with required volume of saliva. The formulation was characterized for microscopy of the piroxicam crystals, sol–gel transition property and in‐vitro diffusion study.
Key findings
Poloxamer‐based formulation enhanced solubility and increased permeability of the piroxicam.
Conclusion
Poloxamer formulation with 0.1% w/w piroxicam delivered a cumulative amount of 11.99 ± 7.82 and 11.23 ± 1.79 μg/cm2, while non‐poloxamer formulation delivered 3.57 ± 2.20 and 4.60 ± 6.90 μg/cm2 with 0.1 and 0.5 ml artificial saliva, respectively, through porcine sublingual tissue in 6 h. A similar delivery profile was observed for 0.05% w/w piroxicam formulation as well.</description><subject>Administration, Sublingual</subject><subject>Animals</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Diffusion</subject><subject>Drug Delivery Systems - methods</subject><subject>Gels - administration & dosage</subject><subject>Gels - chemistry</subject><subject>inverted Franz diffusion cell</subject><subject>Permeability</subject><subject>piroxicam</subject><subject>Piroxicam - administration & dosage</subject><subject>Piroxicam - chemistry</subject><subject>Polymers - administration & dosage</subject><subject>Polymers - chemistry</subject><subject>sol-gel transition</subject><subject>Solutions - administration & dosage</subject><subject>Solutions - chemistry</subject><subject>sublingual delivery</subject><subject>Swine</subject><subject>Temperature</subject><subject>thermosensitive polymer</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAURi0EokNhwwMgS2wQUor_PVmilmmBEXQBFLGxnOSG8eDEwU7aDkueHIdpu2CBN5avz3ds6UPoKSVHNK9X22EzHFEmSn4PLRgRrNBULu-jBSGMFVxqfoAepbQlhGil1EN0wJSmQjC-QL9XIXaTt6MLPbZ9g-HS-ml_DC1OU-Vd_32yHjfg3SXE3TweXAzXrrYdnlK-xuMGYhcS9MmNGcJD8LsOIr5y4yZbsetzcoQGr6Ltf-HGtW0O5idq8P4xetBan-DJzX6IPq_efDo-K9YfT98ev14XtVCSF3rJQMiGEElKqUXVQlPphjWiVrat62pZERCilRUpdSmJAE44rfJkaalQTPND9GLvHWL4OUEaTefS_AHbQ5iSoVqRkmohVUaf_4NuwxT7_LtMyZIzQuksfLmn6hhSitCaIbrOxp2hxMzNmLkZ87eZDD-7UU5VB80deltFBugeuHIedv9RmXfnZ-e30mKfcWmE67uMjT-M0lxLc_Hh1JzIr-9X39ZfzAX_A9LJqoA</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Sivaraman, Arunprasad</creator><creator>Banga, Ajay K.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell</title><author>Sivaraman, Arunprasad ; Banga, Ajay K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4653-782e45d00509574bfedb7d2d4c6afccb8b0e44f5b0979504e3031b44f8a146273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Administration, Sublingual</topic><topic>Animals</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Diffusion</topic><topic>Drug Delivery Systems - methods</topic><topic>Gels - administration & dosage</topic><topic>Gels - chemistry</topic><topic>inverted Franz diffusion cell</topic><topic>Permeability</topic><topic>piroxicam</topic><topic>Piroxicam - administration & dosage</topic><topic>Piroxicam - chemistry</topic><topic>Polymers - administration & dosage</topic><topic>Polymers - chemistry</topic><topic>sol-gel transition</topic><topic>Solutions - administration & dosage</topic><topic>Solutions - chemistry</topic><topic>sublingual delivery</topic><topic>Swine</topic><topic>Temperature</topic><topic>thermosensitive polymer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sivaraman, Arunprasad</creatorcontrib><creatorcontrib>Banga, Ajay K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sivaraman, Arunprasad</au><au>Banga, Ajay K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>2016-01</date><risdate>2016</risdate><volume>68</volume><issue>1</issue><spage>26</spage><epage>35</epage><pages>26-35</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><coden>JPPMAB</coden><abstract>Objectives
The aim of the study was to prepare a sublingual formulation for piroxicam using a thermosensitive polymer and to evaluate its permeation through porcine sublingual mucosa.
Methods
Formulation technique utilized the transition property of poloxamer from solution state at room temperature to gel state at oromucosal temperature (37 °C). The permeation of the drug was evaluated using an inverted Franz diffusion cell technique that allowed the dosage form to be directly applied onto the substrate with required volume of saliva. The formulation was characterized for microscopy of the piroxicam crystals, sol–gel transition property and in‐vitro diffusion study.
Key findings
Poloxamer‐based formulation enhanced solubility and increased permeability of the piroxicam.
Conclusion
Poloxamer formulation with 0.1% w/w piroxicam delivered a cumulative amount of 11.99 ± 7.82 and 11.23 ± 1.79 μg/cm2, while non‐poloxamer formulation delivered 3.57 ± 2.20 and 4.60 ± 6.90 μg/cm2 with 0.1 and 0.5 ml artificial saliva, respectively, through porcine sublingual tissue in 6 h. A similar delivery profile was observed for 0.05% w/w piroxicam formulation as well.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>26714423</pmid><doi>10.1111/jphp.12493</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3573 |
ispartof | Journal of pharmacy and pharmacology, 2016-01, Vol.68 (1), p.26-35 |
issn | 0022-3573 2042-7158 |
language | eng |
recordid | cdi_proquest_miscellaneous_1760917456 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Administration, Sublingual Animals Chemistry, Pharmaceutical - methods Diffusion Drug Delivery Systems - methods Gels - administration & dosage Gels - chemistry inverted Franz diffusion cell Permeability piroxicam Piroxicam - administration & dosage Piroxicam - chemistry Polymers - administration & dosage Polymers - chemistry sol-gel transition Solutions - administration & dosage Solutions - chemistry sublingual delivery Swine Temperature thermosensitive polymer |
title | Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20and%20evaluation%20of%20sublingual%20delivery%20of%20piroxicam%20using%20thermosensitive%20polymer%20with%20an%20inverted%20Franz%20diffusion%20cell&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=Sivaraman,%20Arunprasad&rft.date=2016-01&rft.volume=68&rft.issue=1&rft.spage=26&rft.epage=35&rft.pages=26-35&rft.issn=0022-3573&rft.eissn=2042-7158&rft.coden=JPPMAB&rft_id=info:doi/10.1111/jphp.12493&rft_dat=%3Cproquest_cross%3E1760917456%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1759320117&rft_id=info:pmid/26714423&rfr_iscdi=true |